Comparison of carbapenem breakpoints in Clinical Laboratory Standard Institute and European Committee on Antimicrobial Susceptibility Testing guidelines on antibiotic susceptibility test reporting of Acinetobacter baumannii
Saved in:
Main Authors: | Pravin M. V. Charles (Author), Arunava Kali (Author), Sreenivasan Srirangaraj (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carbapenem-resistant Acinetobacter baumannii in Brazil: susceptibility profile and diversity of oxacillinases
by: Lisiane Rocha, et al.
Published: (2017) -
Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
by: Claudia Alteri, et al.
Published: (2024) -
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
by: Kristian Ängeby, et al. -
Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
by: Montserrat Rodríguez-Aguirregabiria, et al.
Published: (2024) -
<it>In vitro </it>activity of tigecycline and comparators against carbapenem-susceptible and resistant <it>Acinetobacter baumannii </it>clinical isolates in Italy
by: Carattoli Alessandra, et al.
Published: (2008)